Orexins (hypocretins) actions on the GHRH/somatostatin-GH axis

Acta Physiologica

Volumn 198, Issue 3, 2010, Pages 325-334

  Lopez M ^a,b   Nogueiras, R ^a,b   Tena Sempere, M ^b,c   Dieguez C ^a,b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Growth hormone; Growth hormone releasing hormone; Hypothalamus; Orexins hypocretins; Pituitary; Somatostatin

Indexed keywords

GHRELIN; GLUCOSE; GROWTH HORMONE RELEASING FACTOR; LEPTIN; MESSENGER RNA; OREXIN; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; OREXIN A; OREXIN B; SOMATOSTATIN;

CONFERENCE PAPER; DIET RESTRICTION; DRUG MECHANISM; ELECTROSTIMULATION; FEEDING; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HOMEOSTASIS; HORMONE ACTION; HORMONE RELEASE; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; NERVE DEGENERATION; NERVE INJURY; NEUROENDOCRINE SYSTEM; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; PROTEIN EXPRESSION; REM SLEEP; SLEEP; SLEEP DISORDER; SLEEP WAKING CYCLE;

ANIMALS; BODY WEIGHT; EATING; ENERGY METABOLISM; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HOMEOSTASIS; HUMANS; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEURONS; NEUROPEPTIDES; NEUROSECRETORY SYSTEMS; NEUROTRANSMITTER AGENTS; PITUITARY GLAND; SLEEP; SOMATOSTATIN; WAKEFULNESS;

EID: 75749124227     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2009.02042.x     Document Type: Conference Paper

References (121)

1. Acuna-Goycolea, C. van den Pol, A.N. 2009. Neuroendocrine proopiomelanocortin neurons are excited by hypocretin/orexin. J Neurosci 29, 1503 1513.
2. Almli, C.R. Golden, G.T. 1974. Infant rats: effects of lateral hypothalamic destruction. Physiol Behav 13, 81 90.
3. Backberg, M., Hervieu, G., Wilson, S. Meister, B. 2002. Orexin receptor-1 (OX-R1) immunoreactivity in chemically identified neurons of the hypothalamus: focus on orexin targets involved in control of food and water intake. Eur J Neurosci 15, 315 328.
4. Barb, C.R. Matteri, R.L. 2005. Orexin-B modulates luteinizing hormone and growth hormone secretion from porcine pituitary cells in culture. Domest Anim Endocrinol 28, 331 337.
5. Bernardis, L.L. Bellinger, L.L. 1998. The dorsomedial hypothalamic nucleus revisited: 1998 update. Proc Soc Exp Biol Med 218, 284 306.
6. Bertherat, J., Bluet-Pajot, M.T. Epelbaum, J. 1995. Neuroendocrine regulation of growth hormone. Eur J Endocrinol 132, 12 24.
7. Bittencourt, J.C., Presse, F., Arias, C., Peto, C., Vaughan, J., Nahon, J.L., Vale, W. Sawchenko, P.E. 1992. The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J Comp Neurol 319, 218 245.
8. Bjursell, M., Egecioglu, E., Gerdin, A.K., Svensson, L., Oscarsson, J., Morgan, D., Snaith, M., Tornell, J. Bohlooly, Y. 2005. Importance of melanin-concentrating hormone receptor for the acute effects of ghrelin. Biochem Biophys Res Commun 326, 759 765.
9. Blanco, M., López, M., García-Caballero, T., Gallego, R., Vázquez-Boquete, A., Morel, G., Señaris, R.M., Casanueva, F., Diéguez, C. Beiras, A. 2001. Cellular localization of orexin receptors in human pituitary. J Clin Endocrinol Metab 86, 1616 1619. (Pubitemid 32374913)
10. Blanco, M., Gallego, R., García-Caballero, T., Diéguez, C. Beiras, A. 2003. Cellular localization of orexins in human anterior pituitary. Histochem Cell Biol 120, 259 264.
11. Bluet-Pajot, M.T., Epelbaum, J., Gourdji, D., Hammond, C. Kordon, C. 1998. Hypothalamic and hypophyseal regulation of growth hormone secretion. Cell Mol Neurobiol 18, 101 123.
12. Boethel, C.D. 2002. Sleep and the endocrine system: new associations to old diseases. Curr Opin Pulm Med 8, 502 505.
13. Bourgin, P., Huitron-Resendiz, S., Spier, A.D., Fabre, V., Morte, B., Criado, J.R., Sutcliffe, J.G., Henriksen, S.J. de Lecea, L. 2000. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J Neurosci 20, 7760 7765.
14. Bresson, J.L., Clavequin, M.C., Fellmann, D. Bugnon, C. 1989. Human hypothalamic neuronal system revealed with a salmon melanin-concentrating hormone (MCH) antiserum. Neurosci Lett 102, 39 43.
15. Broberger, C., de Lecea, L., Sutcliffe, J.G. Hokfelt, T. 1998. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol 402, 460 474.
16. Broglio, F., Benso, A., Gottero, C., Prodam, F., Grottoli, S., Tassone, F., Maccario, M., Casanueva, F.F., Diéguez, C., Deghenghi, R., Ghigo, E. Arvat, E. 2002. Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans. Clin Endocrinol (Oxf) 57, 265 271.
17. Brownstein, M., Arimura, A., Sato, H., Schally, A.V. Kizer, J.S. 1975. The regional distribution of somatostatin in the rat brain. Endocrinology 96, 1456 1461.
18. Cai, X.J., Widdowson, P.S., Harrold, J., Wilson, S., Buckingham, R.E., Arch, J.R., Tadayyon, M., Clapham, J.C., Wilding, J. Williams, G. 1999. Hypothalamic orexin expression: modulation by blood glucose and feeding. Diabetes 48, 2132 2137.
19. Camanni, F., Ghigo, E. Arvat, E. 1998. Growth hormone-releasing peptides and their analogs. Front Neuroendocrinol 19, 47 72.
20. Campbell, R.E., Grove, K.L. Smith, M.S. 2003. Gonadotropin-releasing hormone neurons coexpress orexin 1 receptor immunoreactivity and receive direct contacts by orexin fibers. Endocrinology 144, 1542 1548.
21. Chemelli, R.M., Willie, J.T., Sinton, C.M., Elmquist, J.K., Scammell, T., Lee, C., Richardson, J.A., Williams, S.C., Xiong, Y., Kisanuki, Y., Fitch, T.E., Nakazato, M., Hammer, R.E., Saper, C.B. Yanagisawa, M. 1999. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98, 437 451.
22. Chen, C. Xu, R. 2003. The in vitro regulation of growth hormone secretion by orexins. Endocrine 22, 57 66.
23. Chen, C.T., Dun, S.L., Kwok, E.H., Dun, N.J. Chang, J.K. 1999. Orexin A-like immunoreactivity in the rat brain. Neurosci Lett 260, 161 164.
24. Clark, R.W., Schmidt, H.S. Malarkey, W.B. 1979. Disordered growth hormone and prolactin secretion in primary disorders of sleep. Neurology 29, 855 861.
25. Daikoku, S., Kawano, H., Noguchi, M., Nakanishi, J., Tokuzen, M., Chihara, K. Nagatsu, I. 1986. GRF neurons in the rat hypothalamus. Brain Res 399, 250 261.
26. Danguir, J. 1986. Intracerebroventricular infusion of somatostatin selectively increases paradoxical sleep in rats. Brain Res 367, 26 30.
27. Danguir, J. Saint-Hilaire, K.S. 1989. Reversal of desipramine-induced suppression of paradoxical sleep by a long-acting somatostatin analogue (octreotide) in rats. Neurosci Lett 98, 154 158.
28. Date, Y., Ueta, Y., Yamashita, H., Yamaguchi, H., Matsukura, S., Kangawa, K., Sakurai, T., Yanagisawa, M. Nakazato, M. 1999. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci USA 96, 748 753.
29. Date, Y., Mondal, M.S., Matsukura, S., Ueta, Y., Yamashita, H., Kaiya, H., Kangawa, K. Nakazato, M. 2000. Distribution of orexin/hypocretin in the rat median eminence and pituitary. Brain Res Mol Brain Res 76, 1 6.
30. Di Vito, L., Broglio, F., Benso, A., Gottero, C., Prodam, F., Papotti, M., Muccioli, G., Diéguez, C., Casanueva, F.F., Deghenghi, R., Ghigo, E. Arvat, E. 2002. The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans. Clin Endocrinol (Oxf) 56, 643 648.
31. Diéguez, C. Casanueva, F.F. 2000. Ghrelin: a step forward in the understanding of somatotroph cell function and growth regulation. Eur J Endocrinol 142, 413 417.
32. Dube, M.G., Kalra, S.P. Kalra, P.S. 1999. Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action. Brain Res 842, 473 477.
33. Edwards, C.M., Abusnana, S., Sunter, D., Murphy, K.G., Ghatei, M.A. Bloom, S.R. 1999. The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J Endocrinol 160, R7 R12.
34. Ehlers, C.L., Reed, T.K. Henriksen, S.J. 1986. Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology 42, 467 474.
35. Elias, C.F., Saper, C.B., Maratos-Flier, E., Tritos, N.A., Lee, C., Kelly, J., Tatro, J.B., Hoffman, G.E., Ollmann, M.M., Barsh, G.S., Sakurai, T., Yanagisawa, M. Elmquist, J.K. 1998. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol 402, 442 459.
36. Fellmann, D., Bugnon, C., Verstegen, J. Lavry, G.N. 1986. Coexpression of human growth hormone-releasing factor 1-37-like and alpha-melanotropin-like immunoreactivities in neurones of the rat lateral dorsal hypothalamus. Neurosci Lett 68, 122 126.
37. Ferguson, A.V. Samson, W.K. 2003. The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic function. Front Neuroendocrinol 24, 141 150.
38. Fitzpatrick-McElligott, S., Card, J.P., Lewis, M.E. Baldino, F., Jr. 1988. Neuronal localization of prosomatostatin mRNA in the rat brain with in situ hybridization histochemistry. J Comp Neurol 273, 558 572.
39. García, M.C., López, M., Gualillo, O., Seoane, L., Diéguez, C. Señarís, R. 2003. Hypothalamic levels of NPY, MCH, and prepro-orexin mRNA during pregnancy and lactation in the rat: role of prolactin. FASEB J 17, 1392 1400.
40. Gerashchenko, D., Kohls, M.D., Greco, M., Waleh, N.S., Salin-Pascual, R., Kilduff, T.S., Lappi, D.A. Shiromani, P.J. 2001. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat. J Neurosci 21, 7273 7283.
41. Gualillo, O., Lago, F., Gomez-Reino, J., Casanueva, F.F. Diéguez, C. 2003. Ghrelin, a widespread hormone: insights into molecular and cellular regulation of its expression and mechanism of action. FEBS Lett 552, 105 109.
42. Hagan, J.J., Leslie, R.A., Patel, S., Evans, M.L., Wattam, T.A., Holmes, S., Benham, C.D., Taylor, S.G., Routledge, C., Hemmati, P. et al. 1999. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA 96, 10911 10916.
43. Hara, J., Beuckmann, C.T., Nambu, T., Willie, J.T., Chemelli, R.M., Sinton, C.M., Sugiyama, F., Yagami, K., Goto, K., Yanagisawa, M. Sakurai, T. 2001. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30, 345 354.
44. Hayashi, M., Shimohira, M., Saisho, S., Shimozawa, K. Iwakawa, Y. 1992. Sleep disturbance in children with growth hormone deficiency. Brain Dev 14, 170 174.
45. Haynes, A.C., Jackson, B., Overend, P., Buckingham, R.E., Wilson, S., Tadayyon, M. Arch, J.R. 1999. Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat. Peptides 20, 1099 1105.
46. Higuchi, T., Takahashi, Y., Takahashi, K., Niimi, Y. Miyasita, A. 1979. Twenty-four-hour secretory patterns of growth hormone, prolactin, and cortisol in narcolepsy. J Clin Endocrinol Metab 49, 197 204.
47. Himsworth, R.L., Carmel, P.W. Frantz, A.G. 1972. The location of the chemoreceptor controlling growth hormone secretion during hypoglycemia in primates. Endocrinology 91, 217 226.
48. Horvath, T.L., Diano, S. van den Pol, A.N. 1999. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J Neurosci 19, 1072 1087.
49. Ida, T., Nakahara, K., Kuroiwa, T., Fukui, K., Nakazato, M., Murakami, T. Murakami, N. 2000. Both corticotropin releasing factor and neuropeptide Y are involved in the effect of orexin (hypocretin) on the food intake in rats. Neurosci Lett 293, 119 122.
50. Iqbal, J., Manley, T.R., Ciofi, P. Clarke, I.J. 2005. Reduction in adiposity affects the extent of afferent projections to growth hormone-releasing hormone and somatostatin neurons and the degree of colocalization of neuropeptides in growth hormone-releasing hormone and somatostatin cells of the ovine hypothalamus. Endocrinology 146, 4776 4785.
51. Johansson, O., Hokfelt, T. Elde, R.P. 1984. Immunohistochemical distribution of somatostatin-like immunoreactivity in the central nervous system of the adult rat. Neuroscience 13, 265 339. (Pubitemid 15211943)
52. Kawakami, M., Kimura, F. Tsai, C.W. 1984. Relationship between the three-hour-period sleep-wakefulness cycle and growth hormone secretion in the immature rat. J Physiol 348, 271 283.
53. Kimura, F. Tsai, C.W. 1984. Ultradian rhythm of growth hormone secretion and sleep in the adult male rat. J Physiol 353, 305 315.
54. Knutson, K.L. Van Cauter, E. 2008. Associations between sleep loss and increased risk of obesity and diabetes. Ann N Y Acad Sci 1129, 287 304.
55. Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H. Kangawa, K. 1999. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656 660.
56. Kukkonen, J.P., Holmqvist, T., Ammoun, S. Akerman, K.E. 2002. Functions of the orexinergic/hypocretinergic system. Am J Physiol Cell Physiol 283, C1567 C1591.
57. de Lecea, L., Kilduff, T.S., Peyron, C., Gao, X., Foye, P.E., Danielson, P.E., Fukuhara, C., Battenberg, E.L., Gautvik, V.T., Bartlett, F.S., Frankel, W.N., van den Pol, A.N., Bloom, F.E., Gautvik, K.M. Sutcliffe, J.G. 1998. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95, 322 327.
58. Lee, M.G., Hassani, O.K. Jones, B.E. 2005. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J Neurosci 25, 6716 6720.
59. van der Lely, A.J., Tschop, M., Heiman, M.L. Ghigo, E. 2004. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25, 426 457.
60. Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P.J., Nishino, S. Mignot, E. 1999. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98, 365 376.
61. Liposits, Z. 1993. Ultrastructure of hypothalamic paraventricular neurons. Crit Rev Neurobiol 7, 89 162.
62. López, M., Señarís, R., Gallego, R., García-Caballero, T., Lago, F., Seoane, L., Casanueva, F. Diéguez, C. 1999. Orexin receptors are expressed in the adrenal medulla of the rat. Endocrinology 140, 5991 5994.
63. López, M., Seoane, L., García, M.C., Lago, F., Casanueva, F.F., Señarís, R. Diéguez, C. 2000. Leptin regulation of prepro-orexin and orexin receptor mRNA levels in the hypothalamus. Biochem Biophys Res Commun 269, 41 45.
64. López, M., Seoane, L., Señarís, R. Diéguez, C. 2001. Prepro-orexin mRNA levels in the rat hypothalamus, and orexin receptors mRNA levels in the rat hypothalamus and adrenal gland are not influenced by the thyroid status. Neurosci Lett 300, 171 175.
65. López, M., Seoane, L.M., García, M.C., Diéguez, C. Señarís, R. 2002. Neuropeptide Y, but not agouti-related peptide or melanin-concentrating hormone, is a target peptide for orexin-a feeding actions in the rat hypothalamus. Neuroendocrinology 75, 34 44.
66. López, M., Seoane, L.M., Tovar, S., Nogueiras, R., Diéguez, C. Señarís, R. 2004. Orexin-A regulates growth hormone releasing hormone mRNA content in a nucleus specific manner and somatostatin mRNA content in a growth hormone-dependent fashion in the rat hypothalamus. Eur J Neurosci 19, 2080 2088.
67. López, M., Lage, R., Tung, Y.C., Challis, B.G., Varela, L., Virtue, S., O'Rahilly, S., Vidal-Puig, A., Diéguez, C. Coll, A.P. 2007. Orexin expression is regulated by alpha-melanocyte-stimulating hormone. J Neuroendocrinol 19, 703 707.
68. Lu, X.Y., Bagnol, D., Burke, S., Akil, H. Watson, S.J. 2000. Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Horm Behav 37, 335 344.
69. Marcus, J.N., Aschkenasi, C.J., Lee, C.E., Chemelli, R.M., Saper, C.B., Yanagisawa, M. Elmquist, J.K. 2001. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435, 6 25.
70. Martynska, L., Polkowska, J., Wolinska-Witort, E., Chmielowska, M., Wasilewska-Dziubinska, E., Bik, W. Baranowska, B. 2006. Orexin A and its role in the regulation of the hypothalamo-pituitary axes in the rat. Reprod Biol 6 (Suppl. 2 29 35.
71. Mignot, E. Thorsby, E. 2001. Narcolepsy and the HLA system. N Engl J Med 344, 692.
72. Mignot, E., Lammers, G.J., Ripley, B., Okun, M., Nevsimalova, S., Overeem, S., Vankova, J., Black, J., Harsh, J., Bassetti, C., Schrader, H. Nishino, S. 2002. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 59, 1553 1562.
73. Mileykovskiy, B.Y., Kiyashchenko, L.I. Siegel, J.M. 2005. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 46, 787 798.
74. Mondal, M.S., Nakazato, M., Date, Y., Murakami, N., Hanada, R., Sakata, T. Matsukura, S. 1999. Characterization of orexin-A and orexin-B in the microdissected rat brain nuclei and their contents in two obese rat models. Neurosci Lett 273, 45 48.
75. Nambu, T., Sakurai, T., Mizukami, K., Hosoya, Y., Yanagisawa, M. Goto, K. 1999. Distribution of orexin neurons in the adult rat brain. Brain Res 827, 243 260.
76. Nishino, S., Ripley, B., Overeem, S., Lammers, G.J. Mignot, E. 2000. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355, 39 40.
77. Nogueiras, R., Perez-Tilve, D., Wortley, K.E. Tschop, M. 2006. Growth hormone secretagogue (ghrelin-) receptors - a complex drug target for the regulation of body weight. CNS Neurol Disord Drug Targets 5, 335 343.
78. Obal, F., Jr. Krueger, J.M. 2001. The somatotropic axis and sleep. Rev Neurol (Paris) 157, S12 S15.
79. Obal, F., Jr., Fang, J., Taishi, P., Kacsoh, B., Gardi, J. Krueger, J.M. 2001. Deficiency of growth hormone-releasing hormone signaling is associated with sleep alterations in the dwarf rat. J Neurosci 21, 2912 2918.
80. Okada, K., Sugihara, H., Minami, S. Wakabayashi, I. 1993. Effect of parenteral administration of selected nutrients and central injection of gamma-globulin from antiserum to neuropeptide Y on growth hormone secretory pattern in food-deprived rats. Neuroendocrinology 57, 678 686.
81. Overeem, S., Kok, S.W., Lammers, G.J., Vein, A.A., Frolich, M., Meinders, A.E., Roelfsema, F. Pijl, H. 2003. Somatotropic axis in hypocretin-deficient narcoleptic humans: altered circadian distribution of GH-secretory events. Am J Physiol Endocrinol Metab 284, E641 E647.
82. Peyron, C., Tighe, D.K., van den Pol, A.N., de Lecea, L., Heller, H.C., Sutcliffe, J.G. Kilduff, T.S. 1998. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18, 9996 10015.
83. Peyron, C., Faraco, J., Rogers, W., Ripley, B., Overeem, S., Charnay, Y., Nevsimalova, S., Aldrich, M., Reynolds, D., Albin, R. et al. 2000. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6, 991 997.
84. Phelps, C.J., Saleh, M.N. Romero, M.I. 1996. Hypophysiotropic somatostatin expression during postnatal development in growth hormone-deficient Ames dwarf mice: peptide immunocytochemistry. Neuroendocrinology 64, 364 378.
85. van den Pol, A.N. 1999. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J Neurosci 19, 3171 3182.
86. van den Pol, A.N. 2000. Narcolepsy: a neurodegenerative disease of the hypocretin system? Neuron 27, 415 418.
87. Pu, S., Jain, M.R., Kalra, P.S. Kalra, S.P. 1998. Orexins, a novel family of hypothalamic neuropeptides, modulate pituitary luteinizing hormone secretion in an ovarian steroid-dependent manner. Regul Pept 78, 133 136.
88. Qu, D., Ludwig, D.S., Gammeltoft, S., Piper, M., Pelleymounter, M.A., Cullen, M.J., Mathes, W.F., Przypek, R., Kanarek, R. Maratos-Flier, E. 1996. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380, 243 247.
89. Quabbe, H.J., Gregor, M., Bumke-Vogt, C., Eckhof, A. Witt, I. 1981. Twenty-four-hour pattern of growth hormone secretion in the rhesus monkey: studies including alterations of the sleep/wake and sleep stage cycles. Endocrinology 109, 513 522.
90. Rettori, V., Milenkovic, L., Aguila, M.C. McCann, S.M. 1990. Physiologically significant effect of neuropeptide Y to suppress growth hormone release by stimulating somatostatin discharge. Endocrinology 126, 2296 2301.
91. Romero, M.I. Phelps, C.J. 1997. Identification of growth hormone-releasing hormone and somatostatin neurons projecting to the median eminence in normal and growth hormone-deficient Ames dwarf mice. Neuroendocrinology 65, 107 116.
92. Russell, S.H., Kim, M.S., Small, C.J., Abbott, C.R., Morgan, D.G., Taheri, S., Murphy, K.G., Todd, J.F., Ghatei, M.A. Bloom, S.R. 2000. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin. J Neuroendocrinol 12, 1213 1218.
93. Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R.M., Tanaka, H., Williams, S.C., Richardson, J.A., Kozlowski, G.P., Wilson, S. et al. 1998. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573 585.
94. Samson, W.K. Taylor, M.M. 2001. Hypocretin/orexin suppresses corticotroph responsiveness in vitro. Am J Physiol Regul Integr Comp Physiol 281, R1140 R1145.
95. Sawchenko, P.E., Swanson, L.W., Rivier, J. Vale, W.W. 1985. The distribution of growth-hormone-releasing factor (GRF) immunoreactivity in the central nervous system of the rat: an immunohistochemical study using antisera directed against rat hypothalamic GRF. J Comp Neurol 237, 100 115.
96. Segal-Lieberman, G., Rubinfeld, H., Glick, M., Kronfeld-Schor, N. Shimon, I. 2006. Melanin-concentrating hormone stimulates human growth hormone secretion: a novel effect of MCH on the hypothalamic-pituitary axis. Am J Physiol Endocrinol Metab 290, E982 E988.
97. Seoane, L.M., Tovar, S., Baldelli, R., Arvat, E., Ghigo, E., Casanueva, F.F. Diéguez, C. 2000. Ghrelin elicits a marked stimulatory effect on GH secretion in freely-moving rats. Eur J Endocrinol 143, R7 R9.
98. Seoane, L.M., López, M., Tovar, S., Casanueva, F., Señarís, R. Diéguez, C. 2003. Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus. Endocrinology 144, 544 551.
99. Seoane, L.M., Tovar, S., Pérez, D., Mallo, F., López, M., Señarís, R., Casanueva, F.F. Diéguez, C. 2004. Orexin A suppresses in vivo GH secretion. Eur J Endocrinol 150, 731 736.
100. Siegel, J.M. 2004. Hypocretin (orexin): role in normal behavior and neuropathology. Annu Rev Psychol 55, 125 148.
101. Skofitsch, G., Jacobowitz, D.M. Zamir, N. 1985. Immunohistochemical localization of a melanin concentrating hormone-like peptide in the rat brain. Brain Res Bull 15, 635 649.
102. Spinazzi, R., Andreis, P.G., Rossi, G.P. Nussdorfer, G.G. 2006. Orexins in the regulation of the hypothalamic-pituitary-adrenal axis. Pharmacol Rev 58, 46 57.
103. Sutcliffe, J.G. de Lecea, L. 2002. The hypocretins: setting the arousal threshold. Nat Rev Neurosci 3, 339 349.
104. Sweet, D.C., Levine, A.S., Billington, C.J. Kotz, C.M. 1999. Feeding response to central orexins. Brain Res 821, 535 538.
105. Taheri, S., Zeitzer, J.M. Mignot, E. 2002. The role of hypocretins (orexins) in sleep regulation and narcolepsy. Annu Rev Neurosci 25, 283 313.
106. Tannenbaum, G.S., Epelbaum, J. Bowers, C.Y. 2003. Interrelationship between the novel peptide ghrelin and somatostatin/growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion. Endocrinology 144, 967 974.
107. Taylor, M.M. Samson, W.K. 2003. The other side of the orexins: endocrine and metabolic actions. Am J Physiol Endocrinol Metab 284, E13 E17.
108. Thannickal, T.C., Moore, R.Y., Nienhuis, R., Ramanathan, L., Gulyani, S., Aldrich, M., Cornford, M. Siegel, J.M. 2000. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27, 469 474.
109. Toppila, J., Asikainen, M., Alanko, L., Turek, F.W., Stenberg, D. Porkka-Heiskanen, T. 1996. The effect of REM sleep deprivation on somatostatin and growth hormone-releasing hormone gene expression in the rat hypothalamus. J Sleep Res 5, 115 122.
110. Toppila, J., Alanko, L., Asikainen, M., Tobler, I., Stenberg, D. Porkka-Heiskanen, T. 1997. Sleep deprivation increases somatostatin and growth hormone-releasing hormone messenger RNA in the rat hypothalamus. J Sleep Res 6, 171 178.
111. Trivedi, P., Yu, H., MacNeil, D.J., Van Der Ploeg, L.H. Guan, X.M. 1998. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett 438, 71 75.
112. Van Cauter, E., Plat, L. Copinschi, G. 1998. Interrelations between sleep and the somatotropic axis. Sleep 21, 553 566.
113. Van Cauter, E., Latta, F., Nedeltcheva, A., Spiegel, K., Leproult, R., Vandenbril, C., Weiss, R., Mockel, J., Legros, J.J. Copinschi, G. 2004. Reciprocal interactions between the GH axis and sleep. Growth Horm IGF Res 14 (Suppl. A 10 17.
114. Van Cauter, E., Holmback, U., Knutson, K., Leproult, R., Miller, A., Nedeltcheva, A., Pannain, S., Penev, P., Tasali, E. Spiegel, K. 2007. Impact of sleep and sleep loss on neuroendocrine and metabolic function. Horm Res 67 (Suppl. 1 2 9.
115. Vincent, S.R., McIntosh, C.H., Buchan, A.M. Brown, J.C. 1985. Central somatostatin systems revealed with monoclonal antibodies. J Comp Neurol 238, 169 186.
116. Willie, J.T., Chemelli, R.M., Sinton, C.M. Yanagisawa, M. 2001. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci 24, 429 458.
117. Wu, R.H. Thorpy, M.J. 1988. Effect of growth hormone treatment on sleep EEGs in growth hormone-deficient children. Sleep 11, 425 429.
118. 2+ currents and synergistically increases growth hormone (GH) secretion with GH-releasing hormone in primary cultured ovine somatotropes. Endocrinology 143, 4609 4619.
119. Xu, R., Roh, S.G., Gong, C., Hernandez, M., Ueta, Y. Chen, C. 2003. Orexin-B augments voltage-gated L-type Ca(2+) current via protein kinase C-mediated signalling pathway in ovine somatotropes. Neuroendocrinology 77, 141 152.
120. Yamanaka, A., Sakurai, T., Katsumoto, T., Yanagisawa, M. Goto, K. 1999. Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight. Brain Res 849, 248 252.
121. Zhang, J., Obal, F., Jr., Fang, J., Collins, B.J. Krueger, J.M. 1996. Non-rapid eye movement sleep is suppressed in transgenic mice with a deficiency in the somatotropic system. Neurosci Lett 220, 97 100.